195 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BDX Becton, Dickinson and Company $257.23 $68.83B Downtrend
Article Searches
BD Introduces New Product to Reduce the Risk of Sepsis http://www.zacks.com/stock/news/373165/bd-introduces-new-product-to-reduce-the-risk-of-sepsis?cid=CS-ZC-FT-373165 Apr 09, 2019 - BD introduces new FDA cleared product to lower the risk of sepsis and combat platelet contamination.
Here's Why You Should Hold Becton, Dickinson Stock for Now http://www.zacks.com/stock/news/371385/heres-why-you-should-hold-becton-dickinson-stock-for-now?cid=CS-ZC-FT-371385 Apr 05, 2019 - Becton, Dickinson (BDX) announces the FDA premarket approval for Venovo venous stent device.
Stock Market News For Mar 15, 2019 http://www.zacks.com/stock/news/359798/stock-market-news-for-mar-15-2019?cid=CS-ZC--359798 Mar 15, 2019 - Wall Street closed mixed on Thursday as investors??? remained anxious about the delay in sealing a U.S. ??? China trade deal.
Here's Why You Should Hold Becton, Dickinson Stock for Now http://www.zacks.com/stock/news/357654/heres-why-you-should-hold-becton-dickinson-stock-for-now?cid=CS-ZC-FT-357654 Mar 05, 2019 - Becton, Dickinson's (BDX) MAX enteric viral panel receives FDA clearance.
Top Analyst Reports for Procter & Gamble, Becton, Dickinson & Dominion Energy http://www.zacks.com/research-daily/211454/top-analyst-reports-for-procter-gamble-becton-dickinson-dominion-energy?cid=CS-ZC-FT-211454 Feb 06, 2019 - Top Analyst Reports for Procter & Gamble, Becton, Dickinson & Dominion Energy
Becton Dickinson and Co (BDX) CEO Vincent Forlenza on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4238318-becton-dickinson-co-bdx-ceo-vincent-forlenza-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Feb 05, 2019 - Becton Dickinson and Co (NYSE:BDX) Q1 2019 Earnings Conference Call February 05, 2019, 08:00 ET Company Participants Monique Dolecki - VP, IR Vincent Forlenza - Chairman & CEO Christopher Reidy -
Becton Dickinson and Co (BDX) Q1 2019 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/05/becton-dickinson-and-co-bdx-q1-2019-earnings-confe.aspx?source=iedfolrf0000001 Feb 05, 2019 - BDX earnings call for the period ending December 31, 2018.
Market Awaits A Flood of Q4 2018 Earnings Data http://www.zacks.com/stock/news/352228/market-awaits-a-flood-of-q4-2018-earnings-data?cid=CS-ZC--352228 Feb 05, 2019 - Market Awaits A Flood of Q4 2018 Earnings Data.
What's in Store for Cardinal Health's (CAH) Q2 Earnings? http://www.zacks.com/stock/news/351730/whats-in-store-for-cardinal-healths-cah-q2-earnings?cid=CS-ZC-FT-351730 Feb 04, 2019 - Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.
Why the Earnings Surprise Streak Could Continue for Becton Dickinson (BDX) http://www.zacks.com/stock/news/350732/why-the-earnings-surprise-streak-could-continue-for-becton-dickinson-bdx?cid=CS-ZC-FT-350732 Jan 30, 2019 - Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Pages: 1234567...20

<Page 2>